SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Inhibikase Therapeutics, Inc. (NASDAQ: IKT)

Core Viewpoint - Purcell & Lefkowitz LLP is investigating Inhibikase Therapeutics, Inc. to determine if the company's directors breached their fiduciary duties related to recent corporate actions [1]. Group 1 - The investigation is being conducted on behalf of Inhibikase Therapeutics's shareholders [1]. - Shareholders interested in their rights and options can obtain additional information through Purcell & Lefkowitz LLP [2]. - The law firm specializes in representing shareholders affected by securities fraud and breaches of fiduciary duty [3].